Theravance Biopharma, Inc. - Ordinary Shares (TBPH): Price and Financial Metrics

Theravance Biopharma, Inc. - Ordinary Shares (TBPH)

Today's Latest Price: $25.11 USD

1.58 (-5.92%)

Updated May 27 4:00pm

Add TBPH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

TBPH Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for TBPH is -0.56 -- better than merely 6.36% of US stocks.
  • TBPH's price/sales ratio is 19.15; that's higher than the P/S ratio of 93.08% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -2.78 for Theravance Biopharma Inc; that's greater than it is for just 4.06% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Theravance Biopharma Inc, a group of peers worth examining would be MXL, NVCN, LJPC, AGIO, and CLLS.
  • TBPH's SEC filings can be seen here. And to visit Theravance Biopharma Inc's official web site, go to
TBPH Daily Price Range
TBPH 52-Week Price Range

TBPH Stock Price Chart More Charts

TBPH Price/Volume Stats

Current price $25.11 52-week high $31.54
Prev. close $26.69 52-week low $15.18
Day low $24.79 Volume 331,200
Day high $26.65 Avg. volume 392,252
50-day MA $25.66 Dividend yield N/A
200-day MA $22.98 Market Cap 1.58B

Theravance Biopharma, Inc. - Ordinary Shares (TBPH) Company Bio

Theravance Biopharma, Inc. engages in the research and development activities focusing on the diseases of the lung and gastrointestinal tract, and infectious diseases, as well as on the acute care setting markets. The company was founded in 2013 and is based in George Town, the Cayman Islands.

TBPH Latest News Stream

Event/TimeNews Detail
Loading, please wait...

TBPH Latest Social Stream

Loading social stream, please wait...

View Full TBPH Social Stream

Latest TBPH News From Around the Web

Below are the latest news stories about Theravance Biopharma Inc that investors may wish to consider to help them evaluate TBPH as an investment opportunity.

Edited Transcript of TBPH earnings conference call or presentation 6-May-20 9:00pm GMT

Q1 2020 Theravance Biopharma Inc Earnings Call

Yahoo | May 25, 2020

Theravance Biopharma Inc (TBPH) Q1 2020 Earnings Call Transcript

TBPH earnings call for the period ending March 31, 2020.

Yahoo | May 8, 2020

Theravance (TBPH) Q1 Earnings Miss, Revenues Beat Estimates

Theravance (TBPH) reports wider- than-expected loss in the first quarter of 2020 while sales beat estimates. The company reiterates 2020 outlook.

Yahoo | May 7, 2020

Theravance Biopharma (TBPH) Reports Q1 Loss, Tops Revenue Estimates

Theravance Bio (TBPH) delivered earnings and revenue surprises of -7.55% and 10.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 6, 2020

Will Theravance Biopharma (TBPH) Report Negative Earnings Next Week? What You Should Know

Theravance Bio (TBPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research | April 29, 2020

Read More 'TBPH' Stories Here

TBPH Price Returns

1-mo -16.69%
3-mo 3.12%
6-mo 15.40%
1-year 46.93%
3-year -32.99%
5-year 80.00%
YTD -3.01%
2019 1.17%
2018 -8.25%
2017 -12.52%
2016 94.51%
2015 9.85%

Continue Researching TBPH

Here are a few links from around the web to help you further your research on Theravance Biopharma Inc's stock as an investment opportunity:

Theravance Biopharma Inc (TBPH) Stock Price | Nasdaq
Theravance Biopharma Inc (TBPH) Stock Quote, History and News - Yahoo Finance
Theravance Biopharma Inc (TBPH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.1054 seconds.